Evidence map›Paper›PMID 29403498›Full record

ArticleFrontiers in immunology2018

Two Distinct Pathways in Mice Generate Antinuclear Antigen-Reactive B Cell Repertoires.

Martin Faderl, Fabian Klein, Oliver F Wirz, Stefan Heiler, Llucia Albertí-Servera, Corinne Engdahl, Jan Andersson, Antonius Rolink

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Ectopic lymphoid structures in the aged lacrimal glands.Clinical immunology (Orlando, Fla.) · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Martin FaderlDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Fabian KleinDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Oliver F WirzDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Stefan HeilerDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Llucia Albertí-ServeraDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Corinne EngdahlDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Jan AnderssonDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Antonius RolinkDevelopmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The escape of anti-self B cells from tolerance mechanisms like clonal deletion, receptor editing, and anergy results in the production of autoantibodies, which is a hallmark of many autoimmune disorders. In this study, we demonstrate that both germline sequences and somatic mutations contribute to autospecificity of B cell clones. For this issue, we investigated the development of antinuclear autoantibodies (ANAs) and their repertoire in two different mouse models. First, in aging mice that were shown to gain several autoimmune features over time including ANAs. Second, in mice undergoing a chronic graft-versus-host disease (GVHD), thereby developing systemic lupus erythematosus-like symptoms. Detailed repertoire analysis revealed that somatic hypermutations (SHM) were present in all Vh and practically all Vl regions of ANAs generated in these two models. The ANA B cell repertoire in aging mice was restricted, dominated by clonally related Vh1-26/Vk4-74 antibodies. In the collection of GVHD-derived ANAs, the repertoire was less restricted, but the usage of the Vh1-26/Vk4-74 combination was still apparent. Germline conversion showed that the SHM in the 4-74 light chain are deterministic for autoreactivity. Detailed analysis revealed that antinuclear reactivity of these antibodies could be induced by a single amino acid substitution in the CDR1 of the Vk4-74. In both aging B6 and young GVHD mice, conversion of the somatic mutations in the Vh and Vl regions of non Vh1-26/Vk4-74 using antibodies showed that B cells with a germline-encoded V gene could also contribute to the ANA-reactive B cell repertoire. These findings indicate that two distinct pathways generate ANA-producing B cells in both model systems. In one pathway, they are generated by Vh1-26/Vk4-74 expressing B cells in the course of immune responses to an antigen that is neither a nuclear antigen nor any other self-antigen. In the other pathway, ANA-producing B cells are derived from progenitors in the bone marrow that express B cell receptors (BCRs), which bind to nuclear antigens and that escape tolerance induction, possibly as a result of crosslinking of their BCRs by multivalent determinants of nuclear antigens.

Indexed as

AgingAmino Acid SubstitutionAnimalsAntibodies, AntinuclearAntibodies, MonoclonalAntigens, NuclearAutoimmunityB-LymphocytesGraft vs Host DiseaseHistonesImmune ToleranceImmunoglobulin Heavy ChainsMiceMice, Inbred C57BLMice, TransgenicMutationAntibodies, AntinuclearAntibodies, MonoclonalAntigens, NuclearHistonesImmunoglobulin Heavy ChainsReceptors, Antigen, B-Cellantinuclear antibodiesautoantibodiesmonoclonal antibodiesmouse modelsomatic hypermutationsystemic lupus erythematosus-like disease

Identifiers

PMID29403498
PMCPMC5786517
OpenAlexW2791926421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.